Automated Fill And Finish For Cell Therapy

Final formulation and filling represent critical control points in cell-based therapy manufacturing, directly dictating dosing accuracy, product consistency, and patient safety. Because sensitive cell types like CAR-T, NK, MSC, and iPSC therapies are highly vulnerable to physical stress, temperature changes, and process variability, manual aliquoting frequently introduces volume inaccuracies, air entrapment, and contamination risks.

Automating this delicate final stage offers a reliable path to protecting therapeutic integrity while maintaining strict GMP compliance. The Gentle P-Pac system uses low-shear mixing, active temperature regulation, and inline air removal to ensure smooth, uniform dispensing across every batch. Uncover how closed-loop, automated processing safeguards cell viability, guarantees precise bag-to-bag dosing, and scales cell therapy manufacturing from clinical trials to commercial production.

Read the application note to explore the full validation data and experimental case studies.